Copper change
NHS to begin clinical trials of copper surfaces in a bid to combat MRSA and other hospital-acquired infections. Siobhan Wagner reports.

Stainless steel hospital surfaces might look spotlessly clean, but the reported 300,000 patients who pick up infections such as MRSA in the UK each year tell a different story.
According to the
, 5,000 of those are likely to die as a result, and it costs the
an estimated £1bn a year.
With this in mind, a Birmingham hospital has launched an 18-month clinical trial to establish whether the installation of copper surfaces will kill MRSA and other hospital-acquired infections.
The trial follows years of laboratory tests at
which established that the natural antimicrobial properties of copper and its alloys dramatically reduce the presence of MRSA compared with stainless steel — the most commonly used surface-metal in health institutions.
Those findings will be put to the test in Selly Oak Hospital, and if the trial is successful, copper surfaces could be installed in hospitals across the UK.
One of the general wards at Selly Oak had all of its bathroom taps, toilet flush-handles, grabs, door handles and push-plates replaced by copper. Even the pens used by staff are copper alloy. All of this is necessary to determine the trial's success because 80 per cent of MRSA transmission is through surface contacts.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Construction industry lags in tech adoption
Are these the best people to ask "Insights from 2,000 Industry Leaders"? - what would their customers views be like (perhaps more...